{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:16:16Z","timestamp":1788441376128,"version":"build-2803163510"},"reference-count":274,"publisher":"IMR Press","issue":"8","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Aging is one of the strongest risk factors for cancer, and its impact is particularly evident in malignancies of the reproductive system. Ovarian, endometrial, cervical, vulvar, prostate, and penile cancers are mainly diagnosed in older adults and often show different clinical and biological features compared with the same tumors in younger patients. Aging is associated with hormonal changes, immune decline, epigenetic alterations, and accumulation of DNA damage, all of which contribute to cancer development and progression. At the same time, many older patients have frailty and multiple comorbidities, which can limit the use of screening programs and invasive diagnostic procedures. This often leads to delayed diagnosis and worse outcomes. Cell-free DNA (cfDNA) is a minimally invasive biomarker that can be obtained from blood samples and provides molecular information on both tumor and host tissues. Circulating DNA reflects tumor-specific alterations but is also influenced by aging-related changes in DNA release, fragmentation, and methylation. For this reason, aging must be considered when cfDNA-based biomarkers are applied in clinical practice. In this review, we describe how aging influences the biology of reproductive system cancers and how these processes are mirrored in cfDNA profiles. We focus on the clinical use of cfDNA for cancer detection and monitoring in older and fragile patients. Special attention is given to repetitive elements in cfDNA, which are strongly affected by aging and tumor-related epigenetic changes and can be detected with high sensitivity even when the tumor fraction is low. We propose an integrative mechanistic framework in which age-related epigenetic and genomic changes influence both tumor biology and cfDNA composition, with transposable elements acting as a central link between aging and cancer.<\/jats:p>","DOI":"10.31083\/fbl50970","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:35:31Z","timestamp":1788438931000},"source":"Crossref","is-referenced-by-count":0,"title":["Aging and Reproductive Cancers: An Integrative View on Cell-Free DNA and Transposable Elements"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4947-5157","authenticated-orcid":true,"given":"Monia","family":"Cecati","sequence":"first","affiliation":[{"name":"Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-1022","authenticated-orcid":true,"given":"Salvatore","family":"Vaiasicca","sequence":"additional","affiliation":[{"name":"Center for Neurobiology of Aging, IRCCS-INRCA, 60121 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-0282","authenticated-orcid":true,"given":"Laura","family":"Cianfruglia","sequence":"additional","affiliation":[{"name":"Advanced Technology Center for Aging Research, IRCCS INRCA, 60121 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5524-741X","authenticated-orcid":true,"given":"Stefania","family":"Fumarola","sequence":"additional","affiliation":[{"name":"Advanced Technology Center for Aging Research, IRCCS INRCA, 60121 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-2734","authenticated-orcid":true,"given":"Roberto","family":"Campagna","sequence":"additional","affiliation":[{"name":"Department for the Promotion of Human Science and Quality of Life, San Raffaele Roma University, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4899-6073","authenticated-orcid":true,"given":"Francesca","family":"Marchegiani","sequence":"additional","affiliation":[{"name":"Clinic of Laboratory and Precision Medicine, IRCCS INRCA, 60121 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-2473","authenticated-orcid":true,"given":"Maurizio","family":"Cardelli","sequence":"additional","affiliation":[{"name":"Advanced Technology Center for Aging Research, IRCCS INRCA, 60121 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Lin HN, Gu XY, Zhang SW, Zeng HM, Wei WW, Zheng RS. Analysis on incidence and mean age at diagnosis for Global Cancer. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 2018; 40: 543\u2013549.","DOI":"10.3760\/cma.j.issn.0253-3766.2018.07.012"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. International Journal of Cancer. 2024; 154: 28\u201340.","DOI":"10.1002\/ijc.34671"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Shah R, Battisti NML, Brain E, Gnangnon FHR, Kanesvaran R, Mohile S, et al. Updated cancer burden in oldest old: A population-based study using 2022 Globocan estimates. Cancer Epidemiology. 2025; 95: 102716.","DOI":"10.1016\/j.canep.2024.102716"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, et al. The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Science Reports. 2022; 5: e936.","DOI":"10.1002\/hsr2.936"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Zhang Y, Luo G, Li M, Guo P, Xiao Y, Ji H, et al. Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis. BMC Cancer. 2019; 19: 984.","DOI":"10.1186\/s12885-019-6139-6"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Li T, Zhang H, Lian M, He Q, Lv M, Zhai L, et al. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. Journal of Hematology & Oncology. 2025; 18: 5.","DOI":"10.1186\/s13045-025-01660-y"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review. European Urology. 2023; 84: 191\u2013206.","DOI":"10.1016\/j.eururo.2023.04.021"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Xu Y, Li R, Wang N, Guo Y, Wang C, Ren Q, et al. Burden trends and risk factors for prostate cancer from 1990 to 2021: a systematic analysis of the Global Burden of Disease Study 2021. Expert Review of Anticancer Therapy. 2025; 25: 1441\u20131450.","DOI":"10.1080\/14737140.2025.2555466"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal For Clinicians. 2021; 71: 209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013; 153: 1194\u20131217.","DOI":"10.1016\/j.cell.2013.05.039"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023; 186: 243\u2013278.","DOI":"10.1016\/j.cell.2022.11.001"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Pawelec G, Derhovanessian E, Larbi A. Immunosenescence and cancer. Critical Reviews in Oncology\/hematology. 2010; 75: 165\u2013172.","DOI":"10.1016\/j.critrevonc.2010.06.012"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen MLG, Extermann M, et al. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2014; 32: 2595\u20132603.","DOI":"10.1200\/JCO.2013.54.8347"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, et al. Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2018; 36: 2326\u20132347.","DOI":"10.1200\/JCO.2018.78.8687"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Yoon KA, Park S, Lee SH, Kim JH, Lee JS. Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. The Journal of Molecular Diagnostics : JMD. 2009; 11: 182\u2013185.","DOI":"10.2353\/jmoldx.2009.080098"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Fumarola S, Cecati M, Marchegiani F, Francini E, Maniscalco R, Sabbatinelli J, et al. Repeatome Analysis of Plasma Circulating DNA in Patients with Cardiovascular Disease: Variation with Cell-Free DNA Integrity\/Length and Clinical Parameters. International Journal of Molecular Sciences. 2025; 26: 6657.","DOI":"10.3390\/ijms26146657"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Science Translational Medicine. 2018; 10: eaat4921.","DOI":"10.1126\/scitranslmed.aat4921"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Arko-Boham B, Aryee NA, Blay RM, Owusu EDA, Tagoe EA, Doris Shackie ES, et al. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers. Cancer Genetics. 2019; 235-236: 65\u201371.","DOI":"10.1016\/j.cancergen.2019.04.062"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Waki K, Yokomizo K, Kawano K, Tsuda N, Komatsu N, Yamada A. Integrity of plasma DNA is inversely correlated with vaccine-induced antitumor immunity in ovarian cancer patients. Cancer Immunology, Immunotherapy : CII. 2020; 69: 2001\u20132007.","DOI":"10.1007\/s00262-020-02599-4"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Zhou H, Zhang X, Liu Q, Yang J, Bai J, Yin M, et al. Can circulating cell free DNA be a promising marker in ovarian cancer? - a genome-scale profiling study in a single institution. Journal of Ovarian Research. 2023; 16: 11.","DOI":"10.1186\/s13048-022-01068-z"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Guo XM, Miller H, Matsuo K, Roman LD, Salhia B. Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature. Cancers. 2021; 13: 838.","DOI":"10.3390\/cancers13040838"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Liang L, Zhang Y, Li C, Liao Y, Wang G, Xu J, et al. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer. EBioMedicine. 2022; 83: 104222.","DOI":"10.1016\/j.ebiom.2022.104222"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Li L, Shan T, Zhang D, Ma F. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study. Journal of the National Cancer Center. 2024; 4: 223\u2013232.","DOI":"10.1016\/j.jncc.2024.05.002"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: a Cancer Journal for Clinicians. 2023; 73: 17\u201348.","DOI":"10.3322\/caac.21763"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Extermann M. Cancer in the Elderly: Moving the Needle Toward Evidence-Based Personalized Oncology. International Journal of Radiation Oncology, Biology, Physics. 2017; 98: 718\u2013720.","DOI":"10.1016\/j.ijrobp.2016.11.005"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Niccoli T, Partridge L. Ageing as a risk factor for disease. Current Biology : CB. 2012; 22: R741\u201352.","DOI":"10.1016\/j.cub.2012.07.024"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"de Sanjos\u00e9 S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. European Journal of Cancer (Oxford, England : 1990). 2013; 49: 3450\u20133461.","DOI":"10.1016\/j.ejca.2013.06.033"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Rajaram S, Maheshwari A, Srivastava A. Staging for vaginal cancer. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2015; 29: 822\u2013832.","DOI":"10.1016\/j.bpobgyn.2015.01.006"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Liu X, Yu C, Bi Y, Zhang ZJ. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health. 2019; 172: 70\u201380.","DOI":"10.1016\/j.puhe.2019.04.016"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Marzioni D, Mazzucchelli R. Cellular Modulators of the NRF2\/KEAP1 Signaling Pathway in Prostate Cancer. Frontiers in Bioscience (Landmark Edition). 2023; 28: 143.","DOI":"10.31083\/j.fbl2807143"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Gesuita R, Montironi R, Marzioni D, Mazzucchelli R. AT-rich interactive domain 1A (ARID1A) cannot be considered a morphological marker for prostate cancer progression: A pilot study. Acta Histochemica. 2022; 124: 151847.","DOI":"10.1016\/j.acthis.2022.151847"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Giona S. The Epidemiology of Penile Cancer. Urologic Cancers.","DOI":"10.36255\/exon-publications-urologic-cancers-epidemiology-penile-cancer"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Loh KP, Liposits G, Arora SP, Neuendorff NR, Gomes F, Krok-Schoen JL, et al. Adequate assessment yields appropriate care-the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO\/SIOG Cancer in the Elderly Working Group. ESMO Open. 2024; 9: 103657.","DOI":"10.1016\/j.esmoop.2024.103657"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Tossetta G, Inversetti A. Ovarian Cancer: Advances in Pathophysiology and Therapies. International Journal of Molecular Sciences. 2023; 24: 8930.","DOI":"10.3390\/ijms24108930"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Fantone S, Marzioni D, Tossetta G. NRF2\/KEAP1 signaling inhibitors in gynecologic cancers. Expert Review of Anticancer Therapy. 2024; 24: 1191\u20131194.","DOI":"10.1080\/14737140.2024.2438951"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Cecati M, Pozzi V, Pompei V, Schiavoni V, Fumarola S, Romagnoli A, et al. Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology. Journal of Xenobiotics. 2026; 16: 9.","DOI":"10.3390\/jox16010009"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Goteri G, Giannubilo SR, Ciavattini A, Marzioni D. The Role of NQO1 in Ovarian Cancer. International Journal of Molecular Sciences. 2023; 24: 7839.","DOI":"10.3390\/ijms24097839"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Hong K, Liu Y, Yin H, Huang K, Pu XL, Zhu ZX. Identifying Factors Contributing to Delayed Diagnosis of Ovarian Cancer: A Comprehensive Analysis. International Journal of Women's Health. 2024; 16: 1463\u20131473.","DOI":"10.2147\/IJWH.S473381"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Wang Y, Shan X, Dong H, Li M, Yue Y. Prediction for 2-year mortality of metastatic ovarian cancer patients based on surveillance, epidemiology, and end results database. Frontiers in Surgery. 2022; 9: 974536.","DOI":"10.3389\/fsurg.2022.974536"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013; 497: 67\u201373.","DOI":"10.1038\/nature12113"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Goyani P, Christodoulou R, Vassiliou E. Immunosenescence: Aging and Immune System Decline. Vaccines. 2024; 12: 1314.","DOI":"10.3390\/vaccines12121314"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"M\u00fcller L, Di Benedetto S. Immunosenescence and inflammaging: Mechanisms and modulation through diet and lifestyle. Frontiers in Immunology. 2025; 16: 1708280.","DOI":"10.3389\/fimmu.2025.1708280"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Bruni L, Serrano B, Roura E, Alemany L, Cowan M, Herrero R, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. The Lancet. Global Health. 2022; 10: e1115\u2013e1127.","DOI":"10.1016\/S2214-109X(22)00241-8"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Carter JS, Downs LS Jr. Vulvar and vaginal cancer. Obstetrics and Gynecology Clinics of North America. 2012; 39: 213\u2013231.","DOI":"10.1016\/j.ogc.2012.04.002"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2015; 131 Suppl 2: S84\u20137.","DOI":"10.1016\/j.ijgo.2015.06.003"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Lin W, Ou Y, Huang H, Xie R, Huang H. Epidemiology of Early Onset Prostate Cancer: Global Patterns, Risk Factors, and Projections Through 2040. Annals of Surgical Oncology. 2025.","DOI":"10.1245\/s10434-025-17665-3"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Cunha GR, Vezina CM, Isaacson D, Ricke WA, Timms BG, Cao M, et al. Development of the human prostate. Differentiation; Research in Biological Diversity. 2018; 103: 24\u201345.","DOI":"10.1016\/j.diff.2018.08.005"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2019; 116: 11428\u201311436.","DOI":"10.1073\/pnas.1902651116"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Research Network. The Molecular Taxonomy of Primary Prostate Cancer. Cell. 2015; 163: 1011\u20131025.","DOI":"10.1016\/j.cell.2015.10.025"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Bechis SK, Carroll PR, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2011; 29: 235\u2013241.","DOI":"10.1200\/JCO.2010.30.2075"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Huang Q, Zi H, Luo L, Li X, Zhu C, Zeng X. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030. BMC Cancer. 2022; 22: 1164.","DOI":"10.1186\/s12885-022-10244-9"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes & Control : CCC. 2009; 20: 449\u2013457.","DOI":"10.1007\/s10552-008-9276-9"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR. Incidence trends in primary malignant penile cancer. Urologic Oncology. 2007; 25: 361\u2013367.","DOI":"10.1016\/j.urolonc.2006.08.029"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Chaux A, Munari E, Katz B, Sharma R, Lecksell K, Cubilla AL, et al. The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases. Human Pathology. 2013; 44: 2690\u20132695.","DOI":"10.1016\/j.humpath.2013.07.012"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Chaux A, Han JS, Lee S, Gonzalez-Roibon N, Sharma R, Burnett AL, et al. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra. Human Pathology. 2013; 44: 2760\u20132767.","DOI":"10.1016\/j.humpath.2013.07.023"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Trama A, Foschi R, Larra\u00f1aga N, Sant M, Fuentes-Raspall R, Serraino D, et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study. European Journal of Cancer (Oxford, England : 1990). 2015; 51: 2206\u20132216.","DOI":"10.1016\/j.ejca.2015.07.027"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Vijg J, Suh Y. Genome instability and aging. Annual Review of Physiology. 2013; 75: 645\u2013668.","DOI":"10.1146\/annurev-physiol-030212-183715"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nature Reviews. Genetics. 2018; 19: 371\u2013384.","DOI":"10.1038\/s41576-018-0004-3"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009; 1: 239\u2013259.","DOI":"10.2217\/epi.09.33"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nature Reviews. Endocrinology. 2018; 14: 576\u2013590.","DOI":"10.1038\/s41574-018-0059-4"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"H\u00fcsing A, Dossus L, Ferrari P, Tj\u00f8nneland A, Hansen L, Fagherazzi G, et al. An epidemiological model for prediction of endometrial cancer risk in Europe. European Journal of Epidemiology. 2016; 31: 51\u201360.","DOI":"10.1007\/s10654-015-0030-9"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nature Medicine. 2004; 10: 33\u201339.","DOI":"10.1038\/nm972"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Klinge CM. Estrogen Regulation of MicroRNA Expression. Current Genomics. 2009; 10: 169\u2013183.","DOI":"10.2174\/138920209788185289"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nature Reviews. Cancer. 2020; 20: 89\u2013106.","DOI":"10.1038\/s41568-019-0222-9"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98: 12072\u201312077.","DOI":"10.1073\/pnas.211053698"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Steinman CR. Free DNA in serum and plasma from normal adults. The Journal of Clinical Investigation. 1975; 56: 512\u2013515.","DOI":"10.1172\/JCI108118"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Wei W, Schon KR, Elgar G, Orioli A, Tanguy M, Giess A, et al. Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes. Nature. 2022; 611: 105\u2013114.","DOI":"10.1038\/s41586-022-05288-7"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Jones KW. Chromosomal and nuclear location of mouse satellite DNA in individual cells. Nature. 1970; 225: 912\u2013915.","DOI":"10.1038\/225912a0"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biology & Therapy. 2019; 20: 1057\u20131067.","DOI":"10.1080\/15384047.2019.1598759"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Zhou Z, Ma MJL, Chan RWY, Lam WKJ, Peng W, Gai W, et al. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs. Proceedings of the National Academy of Sciences of the United States of America. 2023; 120: e2220982120.","DOI":"10.1073\/pnas.2220982120"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Che H, Jiang P, Choy LYL, Cheng SH, Peng W, Chan RWY, et al. Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma. Genome Research. 2024; 34: 189\u2013200.","DOI":"10.1101\/gr.278556.123"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Luo WD, Wang YP, Lv J, Liu Y, Qu YQ, Xu XF, et al. Age-related self-DNA accumulation may accelerate arthritis in rats and in human rheumatoid arthritis. Nature Communications. 2023; 14: 4394.","DOI":"10.1038\/s41467-023-40113-3"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Pessei V, Macagno M, Mariella E, Congiusta N, Battaglieri V, Battuello P, et al. DNA demethylation triggers cell free DNA release in colorectal cancer cells. Genome Medicine. 2024; 16: 118.","DOI":"10.1186\/s13073-024-01386-5"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Tang J, Weiser NE, Wang G, Chowdhry S, Curtis EJ, Zhao Y, et al. Enhancing transcription-replication conflict targets ecDNA-positive cancers. Nature. 2024; 635: 210\u2013218.","DOI":"10.1038\/s41586-024-07802-5"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"De Luca G, Lev PR, Camacho MF, Goette NP, Sackmann F, Castro R\u00edos MA, et al. High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis. Frontiers in Immunology. 2023; 14: 1161832.","DOI":"10.3389\/fimmu.2023.1161832"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Liu X, Liang H, Yan Y, Wu J, Bottini M, Liu L, et al. The protein corona modulates the inflammation inhibition by cationic nanoparticles via cell-free DNA scavenging. Bioactive Materials. 2021; 13: 249\u2013259.","DOI":"10.1016\/j.bioactmat.2021.10.044"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Sedej I, \u0160talekar M, Tu\u0161ek \u017dnidari\u010d M, Gori\u010dar K, Kojc N, Kogov\u0161ek P, et al. Extracellular vesicle-bound DNA in urine is indicative of kidney allograft injury. Journal of Extracellular Vesicles. 2022; 11: e12268.","DOI":"10.1002\/jev2.12268"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Pisetsky DS. Unique Interplay Between Antinuclear Antibodies and Nuclear Molecules in the Pathogenesis of Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). 2024; 76: 1334\u20131343.","DOI":"10.1002\/art.42863"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Luo Z, Ji Y, Gao H, Gomes Dos Reis FC, Bandyopadhyay G, Jin Z, et al. CRIg+ Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance. Gastroenterology. 2021; 160: 863\u2013874.","DOI":"10.1053\/j.gastro.2020.10.042"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Ying C, Li Y, Zhang H, Pang S, Hao S, Hu S, et al. Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson's disease and multiple system atrophy. Frontiers in Neuroscience. 2024; 18: 1488820.","DOI":"10.3389\/fnins.2024.1488820"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Lai P, Liu L, Bancaro N, Troiani M, Cal\u00ec B, Li Y, et al. Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven immunosuppression through the cGAS-STING pathway. Immunity. 2025; 58: 811\u2013825.e7.","DOI":"10.1016\/j.immuni.2025.03.005"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Aubert O, Ursule-Dufait C, Brousse R, Gueguen J, Racap\u00e9 M, Raynaud M, et al. Cell-free DNA for the detection of kidney allograft rejection. Nature Medicine. 2024; 30: 2320\u20132327.","DOI":"10.1038\/s41591-024-03087-3"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Murphy L, Inchausp\u00e9 J, Valenzano G, Holland P, Sousos N, Belnoue-Davis HL, et al. Platelets sequester extracellular DNA, capturing tumor-derived and free fetal DNA. Science (New York, N.Y.). 2025; 389: eadp3971.","DOI":"10.1126\/science.adp3971"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Nakamura Y, Ozaki H, Ueno M, Komatsu Y, Yuki S, Esaki T, et al. Targeted therapy guided by circulating tumor DNA analysis in advanced gastrointestinal tumors. Nature Medicine. 2025; 31: 165\u2013175.","DOI":"10.1038\/s41591-024-03244-8"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Schlaikj\u00e6r Hartwig T, Ambye L, Gruhn JR, Petersen JF, Wr\u00f8nding T, Amato L, et al. Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study. Lancet (London, England). 2023; 401: 762\u2013771.","DOI":"10.1016\/S0140-6736(22)02610-1"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Sadeh R, Sharkia I, Fialkoff G, Rahat A, Gutin J, Chappleboim A, et al. ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin. Nature Biotechnology. 2021; 39: 586\u2013598.","DOI":"10.1038\/s41587-020-00775-6"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Fedyuk V, Erez N, Furth N, Beresh O, Andreishcheva E, Shinde A, et al. Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics. Nature Biotechnology. 2023; 41: 212\u2013221.","DOI":"10.1038\/s41587-022-01447-3"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Lo YMD, Han DSC, Jiang P, Chiu RWK. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science (New York, N.Y.). 2021; 372: eaaw3616.","DOI":"10.1126\/science.aaw3616"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang P, Lun FMF, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine. 2010; 2: 61ra91.","DOI":"10.1126\/scitranslmed.3001720"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Yu SCY, Jiang P, Peng W, Cheng SH, Cheung YTT, Tse OYO, et al. Single-molecule sequencing reveals a large population of long cell-free DNA molecules in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America. 2021; 118: e2114937118.","DOI":"10.1073\/pnas.2114937118"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Yu SCY, Deng J, Qiao R, Cheng SH, Peng W, Lau SL, et al. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma. Clinical Chemistry. 2023; 69: 168\u2013179.","DOI":"10.1093\/clinchem\/hvac180"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Choy LYL, Peng W, Jiang P, Cheng SH, Yu SCY, Shang H, et al. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients. Clinical Chemistry. 2022; 68: 1151\u20131163.","DOI":"10.1093\/clinchem\/hvac086"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Han DSC, Ni M, Chan RWY, Chan VWH, Lui KO, Chiu RWK, et al. The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB. American Journal of Human Genetics. 2020; 106: 202\u2013214.","DOI":"10.1016\/j.ajhg.2020.01.008"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Jiang P, Chan CWM, Chan KCA, Cheng SH, Wong J, Wong VWS, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112: E1317\u201325.","DOI":"10.1073\/pnas.1500076112"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Ma MJL, Zhang H, Jiang P, Sin STK, Lam WKJ, Cheng SH, et al. Topologic Analysis of Plasma Mitochondrial DNA Reveals the Coexistence of Both Linear and Circular Molecules. Clinical Chemistry. 2019; 65: 1161\u20131170.","DOI":"10.1373\/clinchem.2019.308122"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Ma MJL, Yakovenko S, Zhang H, Cheng SH, Apryshko V, Zhavoronkov A, et al. Fetal mitochondrial DNA in maternal plasma in surrogate pregnancies: Detection and topology. Prenatal Diagnosis. 2021; 41: 368\u2013375.","DOI":"10.1002\/pd.5860"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Sin STK, Jiang P, Deng J, Ji L, Cheng SH, Dutta A, et al. Identification and characterization of extrachromosomal circular DNA in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America. 2020; 117: 1658\u20131665.","DOI":"10.1073\/pnas.1914949117"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Sin STK, Ji L, Deng J, Jiang P, Cheng SH, Heung MMS, et al. Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance. Clinical Chemistry. 2021; 67: 788\u2013796.","DOI":"10.1093\/clinchem\/hvaa326"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Kumar P, Dillon LW, Shibata Y, Jazaeri AA, Jones DR, Dutta A. Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation. Molecular Cancer Research : MCR. 2017; 15: 1197\u20131205.","DOI":"10.1158\/1541-7786.MCR-17-0095"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Eugen-Olsen RAB, Hariprakash JM, Oestergaard VH, Regenberg B. Molecular mechanisms of extrachromosomal circular DNA formation. Nucleic Acids Research. 2025; 53: gkaf122.","DOI":"10.1093\/nar\/gkaf122"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Hudecova I, Smith CG, H\u00e4nsel-Hertsch R, Chilamakuri CS, Morris JA, Vijayaraghavan A, et al. Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA. Genome Research. 2022; 32: 215\u2013227.","DOI":"10.1101\/gr.275691.121"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Cheng J, Morselli M, Huang WL, Heo YJ, Pinheiro-Ferreira T, Li F, et al. Plasma contains ultrashort single-stranded DNA in addition to nucleosomal cell-free DNA. iscience. 2022; 25: 104554.","DOI":"10.1016\/j.isci.2022.104554"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Cheng JC, Swarup N, Morselli M, Huang WL, Aziz M, Caggiano C, et al. Single-stranded pre-methylated 5mC adapters uncover the methylation profile of plasma ultrashort Single-stranded cell-free DNA. Nucleic Acids Research. 2024; 52: e50.","DOI":"10.1093\/nar\/gkae276"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"M\u00fcller J, Hartwig C, Sonntag M, Bitzer L, Adelmann C, Vainshtein Y, et al. A novel approach for in vivo DNA footprinting using short double-stranded cell-free DNA from plasma. Genome Research. 2024; 34: 1185\u20131195.","DOI":"10.1101\/gr.279326.124"},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy. 2022; 7: 391.","DOI":"10.1038\/s41392-022-01251-0"},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Flicker L. Should geriatric medicine remain a specialty? Yes. BMJ (Clinical Research Ed.). 2008; 337: a516.","DOI":"10.1136\/bmj.39538.481273.AD"},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2014; 69 Suppl 1: S4\u20139.","DOI":"10.1093\/gerona\/glu057"},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Tessier NP, Hardy LM, Deleuze JF, How-Kit A. Circulating cell-free nucleic acids of plasma in human aging, healthy aging and longevity: current state of knowledge. Frontiers in Genetics. 2023; 14: 1321280.","DOI":"10.3389\/fgene.2023.1321280"},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Meddeb R, Dache ZAA, Thezenas S, Otandault A, Tanos R, Pastor B, et al. Quantifying circulating cell-free DNA in humans. Scientific Reports. 2019; 9: 5220.","DOI":"10.1038\/s41598-019-41593-4"},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Jylh\u00e4v\u00e4 J, Kotipelto T, Raitala A, Jylh\u00e4 M, Hervonen A, Hurme M. Aging is associated with quantitative and qualitative changes in circulating cell-free DNA: the Vitality 90+ study. Mechanisms of Ageing and Development. 2011; 132: 20\u201326.","DOI":"10.1016\/j.mad.2010.11.001"},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"\u00d8rntoft MBW, Jensen S\u00d8, \u00d8gaard N, Henriksen TV, Ferm L, Christensen IJ, et al. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer. International Journal of Cancer. 2021; 148: 1665\u20131675.","DOI":"10.1002\/ijc.33434"},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clinical Chemistry. 2006; 52: 1062\u20131069.","DOI":"10.1373\/clinchem.2006.068577"},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Cardelli M, Pierpaoli E, Marchegiani F, Marcheselli F, Piacenza F, Giacconi R, et al. Biomarkers of cell damage, neutrophil and macrophage activation associated with in-hospital mortality in geriatric COVID-19 patients. Immunity & Ageing : i & a. 2022; 19: 65.","DOI":"10.1186\/s12979-022-00315-7"},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Jylh\u00e4v\u00e4 J, Nevalainen T, Marttila S, Jylh\u00e4 M, Hervonen A, Hurme M. Characterization of the role of distinct plasma cell-free DNA species in age-associated inflammation and frailty. Aging Cell. 2013; 12: 388\u2013397.","DOI":"10.1111\/acel.12058"},{"key":"ref115","doi-asserted-by":"publisher","unstructured":"Singh S, Anshita D, Ravichandiran V. MCP-1: Function, regulation, and involvement in disease. International Immunopharmacology. 2021; 101: 107598.","DOI":"10.1016\/j.intimp.2021.107598"},{"key":"ref116","doi-asserted-by":"publisher","unstructured":"Senatus LM, Schmidt AM. The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases. Frontiers in Genetics. 2017; 8: 187.","DOI":"10.3389\/fgene.2017.00187"},{"key":"ref117","doi-asserted-by":"publisher","unstructured":"Schiavoni V, Emanuelli M, Milanese G, Galosi AB, Pompei V, Salvolini E, et al. Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies. International Journal of Molecular Sciences. 2024; 25: 13239.","DOI":"10.3390\/ijms252413239"},{"key":"ref118","doi-asserted-by":"publisher","unstructured":"Marzioni D, Mazzucchelli R, Fantone S, Tossetta G. NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer. Molecular Biology Reports. 2023; 50: 873\u2013881.","DOI":"10.1007\/s11033-022-08052-2"},{"key":"ref119","doi-asserted-by":"publisher","unstructured":"Campagna R, Serritelli EN, Salvolini E, Schiavoni V, Cecati M, Sartini D, et al. Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes. Biomolecules. 2024; 14: 208.","DOI":"10.3390\/biom14020208"},{"key":"ref120","doi-asserted-by":"publisher","unstructured":"Tossetta G, Fantone S, Olivieri F, Mazzucchelli R, Togni L, Santarelli A, et al. Effect of natural compounds on NRF2\/KEAP1 signaling in periodontitis: a potential use to prevent age-related disorders. Molecular Biology Reports. 2025; 52: 771.","DOI":"10.1007\/s11033-025-10878-5"},{"key":"ref121","doi-asserted-by":"publisher","unstructured":"Roginskaya M, Razskazovskiy Y. Oxidative DNA Damage and Repair: Mechanisms, Mutations, and Relation to Diseases. Antioxidants (Basel, Switzerland). 2023; 12: 1623.","DOI":"10.3390\/antiox12081623"},{"key":"ref122","doi-asserted-by":"publisher","unstructured":"O'Connell GC, Petrone AB, Tennant CS, Lucke-Wold N, Kabbani Y, Tarabishy AR, et al. Circulating extracellular DNA levels are acutely elevated in ischaemic stroke and associated with innate immune system activation. Brain Injury. 2017; 31: 1369\u20131375.","DOI":"10.1080\/02699052.2017.1312018"},{"key":"ref123","doi-asserted-by":"publisher","unstructured":"Falcione SR, Jickling GC. Cell-Free DNA in Ischemic Stroke. Stroke. 2022; 53: 1245\u20131246.","DOI":"10.1161\/STROKEAHA.121.037525"},{"key":"ref124","doi-asserted-by":"publisher","unstructured":"Czaikoski PG, Mota JMSC, Nascimento DC, S\u00f4nego F, Castanheira FVES, Melo PH, et al. Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis. PloS One. 2016; 11: e0148142.","DOI":"10.1371\/journal.pone.0148142"},{"key":"ref125","doi-asserted-by":"publisher","unstructured":"El Tarhouny SA, Hadhoud KM, Ebrahem MM, Al Azizi NM. Assessment of cell-free DNA with microvascular complication of type II diabetes mellitus, using PCR and ELISA. Nucleosides, Nucleotides & Nucleic Acids. 2010; 29: 228\u2013236.","DOI":"10.1080\/15257771003708298"},{"key":"ref126","doi-asserted-by":"publisher","unstructured":"Xu Z, He J, Han P, Dai P, Lv W, Liu N, et al. Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short-term intensive insulin therapy for type 2 diabetes. Clinical and Translational Medicine. 2023; 13: e1437.","DOI":"10.1002\/ctm2.1437"},{"key":"ref127","doi-asserted-by":"publisher","unstructured":"Bartels MS, Scheffler L, Chakaroun R, Dietrich A, Bl\u00fcher M, Stumvoll M, et al. Increased circulating cell-free DNA in insulin resistance. Diabetes & Metabolism. 2020; 46: 249\u2013252.","DOI":"10.1016\/j.diabet.2018.06.004"},{"key":"ref128","doi-asserted-by":"publisher","unstructured":"Berezina TA, Berezin AE. Cell-free DNA as a plausible biomarker of chronic kidney disease. Epigenomics. 2023; 15: 879\u2013890.","DOI":"10.2217\/epi-2023-0255"},{"key":"ref129","doi-asserted-by":"publisher","unstructured":"Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki LM, Pettil\u00e4 V, et al. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Medicine. 2007; 33: 1624\u20131627.","DOI":"10.1007\/s00134-007-0686-z"},{"key":"ref130","doi-asserted-by":"publisher","unstructured":"Chang CPY, Chia RH, Wu TL, Tsao KC, Sun CF, Wu JT. Elevated cell-free serum DNA detected in patients with myocardial infarction. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2003; 327: 95\u2013101.","DOI":"10.1016\/s0009-8981(02)00337-6"},{"key":"ref131","doi-asserted-by":"publisher","unstructured":"Tan E, Liu D, Perry L, Zhu J, Cid-Serra X, Deane A, et al. Cell-free DNA as a potential biomarker for acute myocardial infarction: A systematic review and meta-analysis. International Journal of Cardiology. Heart & Vasculature. 2023; 47: 101246.","DOI":"10.1016\/j.ijcha.2023.101246"},{"key":"ref132","doi-asserted-by":"publisher","unstructured":"Cui M, Fan M, Jing R, Wang H, Qin J, Sheng H, et al. Cell-Free circulating DNA: a new biomarker for the acute coronary syndrome. Cardiology. 2013; 124: 76\u201384.","DOI":"10.1159\/000345855"},{"key":"ref133","doi-asserted-by":"publisher","unstructured":"Xie J, Yang J, Hu P. Correlations of Circulating Cell-Free DNA With Clinical Manifestations in Acute Myocardial Infarction. The American Journal of the Medical Sciences. 2018; 356: 121\u2013129.","DOI":"10.1016\/j.amjms.2018.04.007"},{"key":"ref134","doi-asserted-by":"publisher","unstructured":"Kananen L, Hurme M, Jylh\u00e4 M, H\u00e4rk\u00e4nen T, Koskinen S, Stenholm S, et al. Circulating cell-free DNA level predicts all-cause mortality independent of other predictors in the Health 2000 survey. Scientific Reports. 2020; 10: 13809.","DOI":"10.1038\/s41598-020-70526-9"},{"key":"ref135","doi-asserted-by":"publisher","unstructured":"Yuwono NL, Warton K, Ford CE, et al. The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma. Elife. 2021; 10: e69679.","DOI":"10.7554\/elife.69679"},{"key":"ref136","doi-asserted-by":"publisher","unstructured":"Ma X, Niu M, Ni HM, Ding WX. Mitochondrial dynamics, quality control, and mtDNA in alcohol-associated liver disease and liver cancer. Hepatology (Baltimore, Md.). 2026; 83: 639\u2013660.","DOI":"10.1097\/HEP.0000000000000910"},{"key":"ref137","doi-asserted-by":"publisher","unstructured":"Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, et al. Distinct DNA methylomes of newborns and centenarians. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109: 10522\u201310527.","DOI":"10.1073\/pnas.1120658109"},{"key":"ref138","doi-asserted-by":"publisher","unstructured":"Erichsen L, Beermann A, Arauzo-Bravo MJ, Hassan M, Dkhil MA, Al-Quraishy S, et al. Genome-wide hypomethylation of LINE-1 and Alu retroelements in cell-free DNA of blood is an epigenetic biomarker of human aging. Saudi Journal of Biological Sciences. 2018; 25: 1220\u20131226.","DOI":"10.1016\/j.sjbs.2018.02.005"},{"key":"ref139","doi-asserted-by":"publisher","unstructured":"Teo YV, Capri M, Morsiani C, Pizza G, Faria AMC, Franceschi C, et al. Cell-free DNA as a biomarker of aging. Aging Cell. 2019; 18: e12890.","DOI":"10.1111\/acel.12890"},{"key":"ref140","doi-asserted-by":"publisher","unstructured":"Li SJ, Gao X, Wang ZH, Li J, Zeng LT, Dang YM, et al. Cell-free DNA methylation patterns in aging and their association with inflamm-aging. Epigenomics. 2024; 16: 715\u2013731.","DOI":"10.1080\/17501911.2024.2340958"},{"key":"ref141","doi-asserted-by":"publisher","unstructured":"Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection\u2013systematic review and meta-analysis. Radiology. 2011; 259: 393\u2013405.","DOI":"10.1148\/radiol.11101887"},{"key":"ref142","doi-asserted-by":"publisher","unstructured":"Brawer MK. Prostate-specific antigen. Seminars in Surgical Oncology. 2000; 18: 3\u20139. <3::aid-ssu2>3.0.co;2-i","DOI":"10.1002\/(sici)1098-2388(200001\/02)18:1"},{"key":"ref143","doi-asserted-by":"publisher","unstructured":"Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, et al. Cervical cancer screening. Journal of the National Comprehensive Cancer Network : JNCCN. 2010; 8: 1358\u20131386.","DOI":"10.6004\/jnccn.2010.0103"},{"key":"ref144","doi-asserted-by":"publisher","unstructured":"van den Biggelaar FJHM, Nelemans PJ, Flobbe K. Performance of radiographers in mammogram interpretation: a systematic review. Breast (Edinburgh, Scotland). 2008; 17: 85\u201390.","DOI":"10.1016\/j.breast.2007.07.035"},{"key":"ref145","doi-asserted-by":"publisher","unstructured":"Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nature Reviews. Genetics. 2019; 20: 71\u201388.","DOI":"10.1038\/s41576-018-0071-5"},{"key":"ref146","doi-asserted-by":"publisher","unstructured":"Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998; 17: 89\u201397.","DOI":"10.1097\/00006676-199807000-00012"},{"key":"ref147","doi-asserted-by":"publisher","unstructured":"Herberts C, Wyatt AW. Technical and biological constraints on ctDNA-based genotyping. Trends in Cancer. 2021; 7: 995\u20131009.","DOI":"10.1016\/j.trecan.2021.06.001"},{"key":"ref148","doi-asserted-by":"publisher","unstructured":"Moss EL, Gorsia DN, Collins A, Sandhu P, Foreman N, Gore A, et al. Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression. Cancers. 2020; 12: 2231.","DOI":"10.3390\/cancers12082231"},{"key":"ref149","doi-asserted-by":"publisher","unstructured":"Dawson SJ, Tsui DWY, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. The New England Journal of Medicine. 2013; 368: 1199\u20131209.","DOI":"10.1056\/NEJMoa1213261"},{"key":"ref150","doi-asserted-by":"publisher","unstructured":"Sch\u00fctz E, Akbari MR, Beck J, Urnovitz H, Zhang WW, Bornemann-Kolatzki K, et al. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clinical Chemistry. 2015; 61: 239\u2013248.","DOI":"10.1373\/clinchem.2014.226571"},{"key":"ref151","doi-asserted-by":"publisher","unstructured":"Bidard FC, Madic J, Mariani P, Piperno-Neumann S, Rampanou A, Servois V, et al. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. International Journal of Cancer. 2014; 134: 1207\u20131213.","DOI":"10.1002\/ijc.28436"},{"key":"ref152","doi-asserted-by":"publisher","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Science Translational Medicine. 2014; 6: 224ra24.","DOI":"10.1126\/scitranslmed.3007094"},{"key":"ref153","doi-asserted-by":"publisher","unstructured":"Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2014; 32: 579\u2013586.","DOI":"10.1200\/JCO.2012.45.2011"},{"key":"ref154","doi-asserted-by":"publisher","unstructured":"Hou JY, Chapman JS, Kalashnikova E, Pierson W, Smith-McCune K, Pineda G, et al. Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer. Gynecologic Oncology. 2022; 167: 334\u2013341.","DOI":"10.1016\/j.ygyno.2022.09.004"},{"key":"ref155","doi-asserted-by":"publisher","unstructured":"Christie EL, Fereday S, Doig K, Pattnaik S, Dawson SJ, Bowtell DDL. Reversion of BRCA1\/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2017; 35: 1274\u20131280.","DOI":"10.1200\/JCO.2016.70.4627"},{"key":"ref156","doi-asserted-by":"publisher","unstructured":"Weigelt B, Comino-M\u00e9ndez I, de Bruijn I, Tian L, Meisel JL, Garc\u00eda-Murillas I, et al. Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2017; 23: 6708\u20136720.","DOI":"10.1158\/1078-0432.CCR-17-0544"},{"key":"ref157","doi-asserted-by":"publisher","unstructured":"Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, et al. BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma. Cancer Discovery. 2019; 9: 210\u2013219.","DOI":"10.1158\/2159-8290.CD-18-0715"},{"key":"ref158","doi-asserted-by":"publisher","unstructured":"Shao X, He Y, Ji M, Chen X, Qi J, Shi W, et al. Quantitative analysis of cell-free DNA in ovarian cancer. Oncology Letters. 2015; 10: 3478\u20133482.","DOI":"10.3892\/ol.2015.3771"},{"key":"ref159","doi-asserted-by":"publisher","unstructured":"Ohman AW, Hasan N, Dinulescu DM. Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer. Frontiers in Oncology. 2014; 4: 322.","DOI":"10.3389\/fonc.2014.00322"},{"key":"ref160","doi-asserted-by":"publisher","unstructured":"Ashley CW, Selenica P, Patel J, Wu M, Nincevic J, Lakhman Y, et al. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. 2023; 29: 410\u2013421.","DOI":"10.1158\/1078-0432.CCR-22-1134"},{"key":"ref161","doi-asserted-by":"publisher","unstructured":"Vizza E, Corrado G, De Angeli M, Carosi M, Mancini E, Baiocco E, et al. Serum DNA integrity index as a potential molecular biomarker in endometrial cancer. Journal of Experimental & Clinical Cancer Research : CR. 2018; 37: 16.","DOI":"10.1186\/s13046-018-0688-4"},{"key":"ref162","doi-asserted-by":"publisher","unstructured":"Casas-Arozamena C, Vilar A, Cueva J, Arias E, Sampayo V, Diaz E, et al. Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application. Journal of Experimental & Clinical Cancer Research : CR. 2024; 43: 264.","DOI":"10.1186\/s13046-024-03158-w"},{"key":"ref163","doi-asserted-by":"publisher","unstructured":"Casas-Arozamena C, Moiola CP, Vilar A, Bouso M, Cueva J, Cabrera S, et al. Noninvasive detection of microsatellite instability in patients with endometrial cancer. International Journal of Cancer. 2023; 152: 2206\u20132217.","DOI":"10.1002\/ijc.34435"},{"key":"ref164","doi-asserted-by":"publisher","unstructured":"Bolivar AM, Luthra R, Mehrotra M, Chen W, Barkoh BA, Hu P, et al. Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients. Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. 2019; 32: 405\u2013414.","DOI":"10.1038\/s41379-018-0158-8"},{"key":"ref165","doi-asserted-by":"publisher","unstructured":"Casas-Arozamena C, D\u00edaz E, Moiola CP, Alonso-Alconada L, Ferreir\u00f3s A, Abalo A, et al. Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer. Journal of Clinical Medicine. 2020; 9: 585.","DOI":"10.3390\/jcm9020585"},{"key":"ref166","doi-asserted-by":"publisher","unstructured":"Grassi T, Harris FR, Smadbeck JB, Murphy SJ, Block MS, Multinu F, et al. Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer. PloS One. 2021; 16: e0252390.","DOI":"10.1371\/journal.pone.0252390"},{"key":"ref167","doi-asserted-by":"publisher","unstructured":"Shintani D, Hihara T, Ogasawara A, Sato S, Yabuno A, Tai K, et al. Tumor-related mutations in cell-free DNA in pre-operative plasma as a prognostic indicator of recurrence in endometrial cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 2020; 30: 1340\u20131346.","DOI":"10.1136\/ijgc-2019-001053"},{"key":"ref168","doi-asserted-by":"publisher","unstructured":"Fawzy A, Sweify KM, El-Fayoumy HM, Nofal N. Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence. Journal of the Egyptian National Cancer Institute. 2016; 28: 235\u2013242.","DOI":"10.1016\/j.jnci.2016.08.003"},{"key":"ref169","doi-asserted-by":"publisher","unstructured":"Allen D, Butt A, Cahill D, Wheeler M, Popert R, Swaminathan R. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer. Annals of the New York Academy of Sciences. 2004; 1022: 76\u201380.","DOI":"10.1196\/annals.1318.013"},{"key":"ref170","doi-asserted-by":"publisher","unstructured":"da Silva Filho BF, Gurgel APAD, Neto M\u00c1DFL, de Azevedo DA, de Freitas AC, Silva Neto JDC, et al. Circulating cell-free DNA in serum as a biomarker of colorectal cancer. Journal of Clinical Pathology. 2013; 66: 775\u2013778.","DOI":"10.1136\/jclinpath-2013-201521"},{"key":"ref171","doi-asserted-by":"publisher","unstructured":"Delgado PO, Alves BCA, Gehrke FDS, Kuniyoshi RK, Wroclavski ML, Del Giglio A, et al. Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2013; 34: 983\u2013986.","DOI":"10.1007\/s13277-012-0634-6"},{"key":"ref172","doi-asserted-by":"publisher","unstructured":"Chun FKH, M\u00fcller I, Lange I, Friedrich MG, Erbersdobler A, Karakiewicz PI, et al. Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. BJU International. 2006; 98: 544\u2013548.","DOI":"10.1111\/j.1464-410X.2006.06352.x"},{"key":"ref173","doi-asserted-by":"publisher","unstructured":"Feng J, Gang F, Li X, Jin T, Houbao H, Yu C, et al. Plasma cell-free DNA and its DNA integrity as biomarker to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate-specific antigen. International Urology and Nephrology. 2013; 45: 1023\u20131028.","DOI":"10.1007\/s11255-013-0491-2"},{"key":"ref174","doi-asserted-by":"publisher","unstructured":"Jung K, Stephan C, Lewandowski M, Klotzek S, Jung M, Kristiansen G, et al. Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. Cancer Letters. 2004; 205: 173\u2013180.","DOI":"10.1016\/j.canlet.2003.11.023"},{"key":"ref175","doi-asserted-by":"publisher","unstructured":"Bi\u00e9mont C. A brief history of the status of transposable elements: from junk DNA to major players in evolution. Genetics. 2010; 186: 1085\u20131093.","DOI":"10.1534\/genetics.110.124180"},{"key":"ref176","doi-asserted-by":"publisher","unstructured":"Comfort NC. From controlling elements to transposons: Barbara McClintock and the Nobel Prize. Trends in Genetics : TIG. 2001; 17: 475\u2013478.","DOI":"10.1016\/s0168-9525(01)02383-6"},{"key":"ref177","doi-asserted-by":"publisher","unstructured":"Li TD, Toohill K, Modzelewski AJ. From Junk DNA to Genomic Treasure: Impacts of Transposable Element DNA, RNA, and Protein in Mammalian Development and Disease. Wiley Interdisciplinary Reviews. RNA. 2025; 16: e70022.","DOI":"10.1002\/wrna.70022"},{"key":"ref178","doi-asserted-by":"publisher","unstructured":"Nurk S, Koren S, Rhie A, Rautiainen M, Bzikadze AV, Mikheenko A, et al. The complete sequence of a human genome. Science (New York, N.Y.). 2022; 376: 44\u201353.","DOI":"10.1126\/science.abj6987"},{"key":"ref179","doi-asserted-by":"publisher","unstructured":"Wells JN, Feschotte C. A Field Guide to Eukaryotic Transposable Elements. Annual Review of Genetics. 2020; 54: 539\u2013561.","DOI":"10.1146\/annurev-genet-040620-022145"},{"key":"ref180","doi-asserted-by":"publisher","unstructured":"Mosaddeghi P, Farahmandnejad M, Zarshenas MM. The role of transposable elements in aging and cancer. Biogerontology. 2023; 24: 479\u2013491.","DOI":"10.1007\/s10522-023-10028-z"},{"key":"ref181","doi-asserted-by":"publisher","unstructured":"Ghanim GE, Hu H, Boulanger J, Nguyen THD. Structural mechanism of LINE-1 target-primed reverse transcription. Science. 2025; 388: eads8412.","DOI":"10.1126\/science.ads8412"},{"key":"ref182","doi-asserted-by":"publisher","unstructured":"J\u00f6nsson ME, Garza R, Johansson PA, Jakobsson J. Transposable Elements: A Common Feature of Neurodevelopmental and Neurodegenerative Disorders. Trends in Genetics : TIG. 2020; 36: 610\u2013623.","DOI":"10.1016\/j.tig.2020.05.004"},{"key":"ref183","doi-asserted-by":"publisher","unstructured":"Han JS. Non-long terminal repeat (non-LTR) retrotransposons: mechanisms, recent developments, and unanswered questions. Mobile DNA. 2010; 1: 15.","DOI":"10.1186\/1759-8753-1-15"},{"key":"ref184","doi-asserted-by":"publisher","unstructured":"Rybacki K, Xia M, Ahsan MU, Xing J, Wang K. Assessing the Expression of Long INterspersed Elements (LINEs) via Long-Read Sequencing in Diverse Human Tissues and Cell Lines. Genes. 2023; 14: 1893.","DOI":"10.3390\/genes14101893"},{"key":"ref185","doi-asserted-by":"publisher","unstructured":"Hancks DC, Kazazian HH Jr. Roles for retrotransposon insertions in human disease. Mobile DNA. 2016; 7: 9.","DOI":"10.1186\/s13100-016-0065-9"},{"key":"ref186","doi-asserted-by":"publisher","unstructured":"Mills RE, Bennett EA, Iskow RC, Devine SE. Which transposable elements are active in the human genome? Trends in Genetics : TIG. 2007; 23: 183\u2013191.","DOI":"10.1016\/j.tig.2007.02.006"},{"key":"ref187","doi-asserted-by":"publisher","unstructured":"Burns KH. Transposable elements in cancer. Nature Reviews. Cancer. 2017; 17: 415\u2013424.","DOI":"10.1038\/nrc.2017.35"},{"key":"ref188","doi-asserted-by":"publisher","unstructured":"de Cubas AA, Dunker W, Zaninovich A, Hongo RA, Bhatia A, Panda A, et al. DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. JCI Insight. 2020; 5: e137569.","DOI":"10.1172\/jci.insight.137569"},{"key":"ref189","doi-asserted-by":"publisher","unstructured":"Grundy EE, Diab N, Chiappinelli KB. Transposable element regulation and expression in cancer. The FEBS Journal. 2022; 289: 1160\u20131179.","DOI":"10.1111\/febs.15722"},{"key":"ref190","doi-asserted-by":"publisher","unstructured":"Fort A, Hashimoto K, Yamada D, Salimullah M, Keya CA, Saxena A, et al. Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance. Nature Genetics. 2014; 46: 558\u2013566.","DOI":"10.1038\/ng.2965"},{"key":"ref191","doi-asserted-by":"publisher","unstructured":"Garcia-Perez JL, Marchetto MCN, Muotri AR, Coufal NG, Gage FH, O'Shea KS, et al. LINE-1 retrotransposition in human embryonic stem cells. Human Molecular Genetics. 2007; 16: 1569\u20131577.","DOI":"10.1093\/hmg\/ddm105"},{"key":"ref192","doi-asserted-by":"publisher","unstructured":"Baillie JK, Barnett MW, Upton KR, Gerhardt DJ, Richmond TA, De Sapio F, et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature. 2011; 479: 534\u2013537.","DOI":"10.1038\/nature10531"},{"key":"ref193","doi-asserted-by":"publisher","unstructured":"Hermant C, Torres-Padilla ME. TFs for TEs: the transcription factor repertoire of mammalian transposable elements. Genes & Development. 2021; 35: 22\u201339.","DOI":"10.1101\/gad.344473.120"},{"key":"ref194","doi-asserted-by":"publisher","unstructured":"Chaaban A, Sleem R, Santina J, Rima M, Ibrahim JN. Exploring transposable elements: new horizons in cancer diagnostics and therapeutics. Mobile DNA. 2025; 16: 28.","DOI":"10.1186\/s13100-025-00366-9"},{"key":"ref195","doi-asserted-by":"publisher","unstructured":"Nicolau M, Picault N, Moissiard G. The Evolutionary Volte-Face of Transposable Elements: From Harmful Jumping Genes to Major Drivers of Genetic Innovation. Cells. 2021; 10: 2952.","DOI":"10.3390\/cells10112952"},{"key":"ref196","doi-asserted-by":"publisher","unstructured":"Huang CRL, Burns KH, Boeke JD. Active transposition in genomes. Annual Review of Genetics. 2012; 46: 651\u2013675.","DOI":"10.1146\/annurev-genet-110711-155616"},{"key":"ref197","doi-asserted-by":"publisher","unstructured":"Bourque G, Burns KH, Gehring M, Gorbunova V, Seluanov A, Hammell M, et al. Ten things you should know about transposable elements. Genome Biology. 2018; 19: 199.","DOI":"10.1186\/s13059-018-1577-z"},{"key":"ref198","doi-asserted-by":"publisher","unstructured":"Beck CR, Garcia-Perez JL, Badge RM, Moran JV. LINE-1 elements in structural variation and disease. Annual Review of Genomics and Human Genetics. 2011; 12: 187\u2013215.","DOI":"10.1146\/annurev-genom-082509-141802"},{"key":"ref199","doi-asserted-by":"publisher","unstructured":"Burns KH, Boeke JD. Human transposon tectonics. Cell. 2012; 149: 740\u2013752.","DOI":"10.1016\/j.cell.2012.04.019"},{"key":"ref200","doi-asserted-by":"publisher","unstructured":"Xing J, Zhang Y, Han K, Salem AH, Sen SK, Huff CD, et al. Mobile elements create structural variation: analysis of a complete human genome. Genome Research. 2009; 19: 1516\u20131526.","DOI":"10.1101\/gr.091827.109"},{"key":"ref201","doi-asserted-by":"publisher","unstructured":"Ewing AD, Kazazian HH Jr. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Research. 2010; 20: 1262\u20131270.","DOI":"10.1101\/gr.106419.110"},{"key":"ref202","doi-asserted-by":"publisher","unstructured":"Kazazian HH Jr. Mobile DNA transposition in somatic cells. BMC Biology. 2011; 9: 62.","DOI":"10.1186\/1741-7007-9-62"},{"key":"ref203","doi-asserted-by":"publisher","unstructured":"Klawitter S, Fuchs NV, Upton KR, Mu\u00f1oz-Lopez M, Shukla R, Wang J, et al. Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells. Nature Communications. 2016; 7: 10286.","DOI":"10.1038\/ncomms10286"},{"key":"ref204","doi-asserted-by":"publisher","unstructured":"Erwin JA, Marchetto MC, Gage FH. Mobile DNA elements in the generation of diversity and complexity in the brain. Nature Reviews. Neuroscience. 2014; 15: 497\u2013506.","DOI":"10.1038\/nrn3730"},{"key":"ref205","doi-asserted-by":"publisher","unstructured":"Muotri AR, Chu VT, Marchetto MCN, Deng W, Moran JV, Gage FH. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature. 2005; 435: 903\u2013910.","DOI":"10.1038\/nature03663"},{"key":"ref206","doi-asserted-by":"publisher","unstructured":"Evrony GD, Lee E, Park PJ, Walsh CA. Resolving rates of mutation in the brain using single-neuron genomics. elife. 2016; 5: e12966.","DOI":"10.7554\/eLife.12966"},{"key":"ref207","doi-asserted-by":"publisher","unstructured":"Upton KR, Gerhardt DJ, Jesuadian JS, Richardson SR, S\u00e1nchez-Luque FJ, Bodea GO, et al. Ubiquitous L1 mosaicism in hippocampal neurons. Cell. 2015; 161: 228\u2013239.","DOI":"10.1016\/j.cell.2015.03.026"},{"key":"ref208","doi-asserted-by":"publisher","unstructured":"Treiber CD, Waddell S. Resolving the prevalence of somatic transposition in Drosophila. elife. 2017; 6: e28297.","DOI":"10.7554\/eLife.28297"},{"key":"ref209","doi-asserted-by":"publisher","unstructured":"Iskow RC, McCabe MT, Mills RE, Torene S, Pittard WS, Neuwald AF, et al. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell. 2010; 141: 1253\u20131261.","DOI":"10.1016\/j.cell.2010.05.020"},{"key":"ref210","doi-asserted-by":"publisher","unstructured":"Lee E, Iskow R, Yang L, Gokcumen O, Haseley P, Luquette LJ 3rd, et al. Landscape of somatic retrotransposition in human cancers. Science (New York, N.Y.). 2012; 337: 967\u2013971.","DOI":"10.1126\/science.1222077"},{"key":"ref211","doi-asserted-by":"publisher","unstructured":"Tubio JMC, Li Y, Ju YS, Martincorena I, Cooke SL, Tojo M, et al. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science (New York, N.Y.). 2014; 345: 1251343.","DOI":"10.1126\/science.1251343"},{"key":"ref212","doi-asserted-by":"publisher","unstructured":"Scott EC, Gardner EJ, Masood A, Chuang NT, Vertino PM, Devine SE. A hot L1 retrotransposon evades somatic repression and initiates human colorectal cancer. Genome Research. 2016; 26: 745\u2013755.","DOI":"10.1101\/gr.201814.115"},{"key":"ref213","doi-asserted-by":"publisher","unstructured":"Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100: 5280\u20135285.","DOI":"10.1073\/pnas.0831042100"},{"key":"ref214","doi-asserted-by":"publisher","unstructured":"Gorbunova V, Boeke JD, Helfand SL, Sedivy JM. Human Genomics. Sleeping dogs of the genome. Science (New York, N.Y.). 2014; 346: 1187\u20131188.","DOI":"10.1126\/science.aaa3177"},{"key":"ref215","doi-asserted-by":"publisher","unstructured":"Merenciano M, Larue A, Garambois C, Nunes WVB, Vieira C. Exploring the Relationship of Transposable Elements and Ageing: Causes and Consequences. Genome Biology and Evolution. 2025; 17: evaf088.","DOI":"10.1093\/gbe\/evaf088"},{"key":"ref216","doi-asserted-by":"publisher","unstructured":"Williams GC. Pleiotropy, Natural Selection, and the Evolution of Senescence: Evolution 11, 398\u2013411 (1957). Science of Aging Knowledge Environment. 2001; 1: cp13\u2013cp13.","DOI":"10.1126\/sageke.2001.1.cp13"},{"key":"ref217","doi-asserted-by":"publisher","unstructured":"Copley KE, Shorter J. Repetitive elements in aging and neurodegeneration. Trends in Genetics : TIG. 2023; 39: 381\u2013400.","DOI":"10.1016\/j.tig.2023.02.008"},{"key":"ref218","doi-asserted-by":"publisher","unstructured":"Yushkova E, Moskalev A. Transposable elements and their role in aging. Ageing Research Reviews. 2023; 86: 101881.","DOI":"10.1016\/j.arr.2023.101881"},{"key":"ref219","doi-asserted-by":"crossref","unstructured":"Shmookler Reis RJ, Goldstein S. Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. The Journal of Biological Chemistry. 1983; 258: 9078\u20139085.","DOI":"10.1016\/S0021-9258(17)44633-3"},{"key":"ref220","doi-asserted-by":"publisher","unstructured":"Vijg J, Mullaart E, Lohman PH, Knook DL. UV-induced unscheduled DNA synthesis in fibroblasts of aging inbred rats. Mutation Research. 1985; 146: 197\u2013204.","DOI":"10.1016\/0167-8817(85)90011-2"},{"key":"ref221","doi-asserted-by":"publisher","unstructured":"Murray V. Are transposons a cause of ageing? Mutation Research. 1990; 237: 59\u201363.","DOI":"10.1016\/0921-8734(90)90011-f"},{"key":"ref222","doi-asserted-by":"publisher","unstructured":"Wood JG, Jones BC, Jiang N, Chang C, Hosier S, Wickremesinghe P, et al. Chromatin-modifying genetic interventions suppress age-associated transposable element activation and extend life span in Drosophila. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113: 11277\u201311282.","DOI":"10.1073\/pnas.1604621113"},{"key":"ref223","doi-asserted-by":"publisher","unstructured":"Simon M, Van Meter M, Ablaeva J, Ke Z, Gonzalez RS, Taguchi T, et al. LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation. Cell Metabolism. 2019; 29: 871\u2013885.e5.","DOI":"10.1016\/j.cmet.2019.02.014"},{"key":"ref224","doi-asserted-by":"publisher","unstructured":"Gorbunova V, Seluanov A, Mita P, McKerrow W, Feny\u00f6 D, Boeke JD, et al. The role of retrotransposable elements in ageing and age-associated diseases. Nature. 2021; 596: 43\u201353.","DOI":"10.1038\/s41586-021-03542-y"},{"key":"ref225","doi-asserted-by":"publisher","unstructured":"Slotkin RK, Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nature Reviews. Genetics. 2007; 8: 272\u2013285.","DOI":"10.1038\/nrg2072"},{"key":"ref226","doi-asserted-by":"publisher","unstructured":"Li W, Prazak L, Chatterjee N, Gr\u00fcninger S, Krug L, Theodorou D, et al. Activation of transposable elements during aging and neuronal decline in Drosophila. Nature Neuroscience. 2013; 16: 529\u2013531.","DOI":"10.1038\/nn.3368"},{"key":"ref227","doi-asserted-by":"publisher","unstructured":"De Cecco M, Criscione SW, Peterson AL, Neretti N, Sedivy JM, Kreiling JA. Transposable elements become active and mobile in the genomes of aging mammalian somatic tissues. Aging. 2013; 5: 867\u2013883.","DOI":"10.18632\/aging.100621"},{"key":"ref228","doi-asserted-by":"publisher","unstructured":"Chen H, Zheng X, Xiao D, Zheng Y. Age-associated de-repression of retrotransposons in the Drosophila fat body, its potential cause and consequence. Aging Cell. 2016; 15: 542\u2013552.","DOI":"10.1111\/acel.12465"},{"key":"ref229","doi-asserted-by":"publisher","unstructured":"Yang N, Srivastav SP, Rahman R, Ma Q, Dayama G, Li S, et al. Transposable element landscapes in aging Drosophila. PLoS Genetics. 2022; 18: e1010024.","DOI":"10.1371\/journal.pgen.1010024"},{"key":"ref230","doi-asserted-by":"publisher","unstructured":"Hotzi B, Vellai T. Transposable element methylation tracks age. Nature Aging. 2025; 5: 179\u2013181.","DOI":"10.1038\/s43587-025-00807-3"},{"key":"ref231","doi-asserted-by":"publisher","unstructured":"Jintaridth P, Mutirangura A. Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences. Physiological Genomics. 2010; 41: 194\u2013200.","DOI":"10.1152\/physiolgenomics.00146.2009"},{"key":"ref232","doi-asserted-by":"publisher","unstructured":"Tsurumi A, Li WX. Global heterochromatin loss: a unifying theory of aging? Epigenetics. 2012; 7: 680\u2013688.","DOI":"10.4161\/epi.20540"},{"key":"ref233","doi-asserted-by":"publisher","unstructured":"Pal S, Tyler JK. Epigenetics and aging. Science Advances. 2016; 2: e1600584.","DOI":"10.1126\/sciadv.1600584"},{"key":"ref234","doi-asserted-by":"publisher","unstructured":"Sen P, Shah PP, Nativio R, Berger SL. Epigenetic Mechanisms of Longevity and Aging. Cell. 2016; 166: 822\u2013839.","DOI":"10.1016\/j.cell.2016.07.050"},{"key":"ref235","doi-asserted-by":"publisher","unstructured":"Kane AE, Sinclair DA. Epigenetic changes during aging and their reprogramming potential. Critical Reviews in Biochemistry and Molecular Biology. 2019; 54: 61\u201383.","DOI":"10.1080\/10409238.2019.1570075"},{"key":"ref236","doi-asserted-by":"publisher","unstructured":"Yang JH, Hayano M, Griffin PT, Amorim JA, Bonkowski MS, Apostolides JK, et al. Loss of epigenetic information as a cause of mammalian aging. Cell. 2023; 186: 305\u2013326.e27.","DOI":"10.1016\/j.cell.2022.12.027"},{"key":"ref237","doi-asserted-by":"publisher","unstructured":"Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biology. 2004; 6: 168\u2013170.","DOI":"10.1038\/ncb1095"},{"key":"ref238","doi-asserted-by":"publisher","unstructured":"Gorbunova V, Seluanov A. DNA double strand break repair, aging and the chromatin connection. Mutation Research. 2016; 788: 2\u20136.","DOI":"10.1016\/j.mrfmmm.2016.02.004"},{"key":"ref239","doi-asserted-by":"publisher","unstructured":"Sedivy JM, Kreiling JA, Neretti N, De Cecco M, Criscione SW, Hofmann JW, et al. Death by transposition - the enemy within? BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology. 2013; 35: 1035\u20131043.","DOI":"10.1002\/bies.201300097"},{"key":"ref240","doi-asserted-by":"publisher","unstructured":"De Cecco M, Ito T, Petrashen AP, Elias AE, Skvir NJ, Criscione SW, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature. 2019; 566: 73\u201378.","DOI":"10.1038\/s41586-018-0784-9"},{"key":"ref241","doi-asserted-by":"publisher","unstructured":"De Santis I, Zanoni M, Pignatta S, Longobardi P, Tesei A, Bevilacqua A. Pro-inflammatory RNA:DNA Hybrids Are p53 Independently Boosted by Hyperbaric Oxygen: a Subcellular Distribution Analysis by Automated Quantitative Imaging. Molecular Imaging and Biology. 2023; 25: 504\u2013512.","DOI":"10.1007\/s11307-022-01778-2"},{"key":"ref242","doi-asserted-by":"publisher","unstructured":"Hopfner KP, Hornung V. Molecular mechanisms and cellular functions of cGAS-STING signalling. Nature Reviews. Molecular Cell Biology. 2020; 21: 501\u2013521.","DOI":"10.1038\/s41580-020-0244-x"},{"key":"ref243","doi-asserted-by":"publisher","unstructured":"Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science (New York, N.Y.). 2011; 331: 593\u2013596.","DOI":"10.1126\/science.1200801"},{"key":"ref244","doi-asserted-by":"publisher","unstructured":"Rodi\u0107 N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology. 2014; 184: 1280\u20131286.","DOI":"10.1016\/j.ajpath.2014.01.007"},{"key":"ref245","doi-asserted-by":"publisher","unstructured":"Ladoukakis E, Andriamiadana G, Hajizadah F, James LGE, Nedjai B. Epigenetic Biomarkers for Cervical Cancer Progression: A Scoping Review. International Journal of Molecular Sciences. 2025; 26: 9423.","DOI":"10.3390\/ijms26199423"},{"key":"ref246","doi-asserted-by":"publisher","unstructured":"Tunbak H, Deniz \u00d6. Reawakening retrotransposons: immune modulation in normal and malignant hematopoiesis. Trends in Cancer. 2025; 11: 1106\u20131117.","DOI":"10.1016\/j.trecan.2025.07.006"},{"key":"ref247","doi-asserted-by":"publisher","unstructured":"Arachchillage DPW, Udomsinprasert W. Long interspersed nuclear element 1 methylation in non-small cell lung cancer: implications for diagnosis, prognosis, and therapeutic targeting. Cell Communication and Signaling : CCS. 2025; 23: 350.","DOI":"10.1186\/s12964-025-02343-4"},{"key":"ref248","doi-asserted-by":"publisher","unstructured":"Zhang T, Zhao W, Wirth C, D\u00edaz-Gay M, Yin J, Cecati M, et al. Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma. Nature. 2026; 650: 230\u2013241.","DOI":"10.1038\/s41586-025-09825-y"},{"key":"ref249","doi-asserted-by":"publisher","unstructured":"Bersani F, Lee E, Kharchenko PV, Xu AW, Liu M, Xega K, et al. Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112: 15148\u201315153.","DOI":"10.1073\/pnas.1518008112"},{"key":"ref250","doi-asserted-by":"publisher","unstructured":"Dong W, Li M, Li P, Hou X, He F, Ji S. Transposons disrupt genomic stability and trigger cancers. Frontiers in Cellular and Infection Microbiology. 2025; 15: 1704405.","DOI":"10.3389\/fcimb.2025.1704405"},{"key":"ref251","doi-asserted-by":"publisher","unstructured":"Fueyo R, Judd J, Feschotte C, Wysocka J. Roles of transposable elements in the regulation of mammalian transcription. Nature Reviews. Molecular Cell Biology. 2022; 23: 481\u2013497.","DOI":"10.1038\/s41580-022-00457-y"},{"key":"ref252","doi-asserted-by":"publisher","unstructured":"Grinwald MF, Saintilnord WN, Wang T. Unmasked: transposable elements as drivers and targets in cancer. Trends in Genetics : TIG. 2026; 42: 30\u201345.","DOI":"10.1016\/j.tig.2025.08.002"},{"key":"ref253","doi-asserted-by":"publisher","unstructured":"Samuelson LC, Wiebauer K, Snow CM, Meisler MH. Retroviral and pseudogene insertion sites reveal the lineage of human salivary and pancreatic amylase genes from a single gene during primate evolution. Molecular and Cellular Biology. 1990; 10: 2513\u20132520.","DOI":"10.1128\/mcb.10.6.2513-2520.1990"},{"key":"ref254","doi-asserted-by":"publisher","unstructured":"Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, Zamora J, Supek F, Demeulemeester J, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nature Genetics. 2020; 52: 306\u2013319.","DOI":"10.1038\/s41588-019-0562-0"},{"key":"ref255","doi-asserted-by":"publisher","unstructured":"Fukuda K. The role of transposable elements in human evolution and methods for their functional analysis: current status and future perspectives. Genes & Genetic Systems. 2024; 98: 289\u2013304.","DOI":"10.1266\/ggs.23-00140"},{"key":"ref256","doi-asserted-by":"publisher","unstructured":"McCue AD, Nuthikattu S, Reeder SH, Slotkin RK. Gene expression and stress response mediated by the epigenetic regulation of a transposable element small RNA. PLoS Genetics. 2012; 8: e1002474.","DOI":"10.1371\/journal.pgen.1002474"},{"key":"ref257","doi-asserted-by":"publisher","unstructured":"Gebrie A. Transposable elements as essential elements in the control of gene expression. Mobile DNA. 2023; 14: 9.","DOI":"10.1186\/s13100-023-00297-3"},{"key":"ref258","doi-asserted-by":"publisher","unstructured":"Grundy EE, Shaw LC, Wang L, Lee AV, Argueta JC, Powell DJ Jr, et al. A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitope. Mobile DNA. 2024; 15: 19.","DOI":"10.1186\/s13100-024-00333-w"},{"key":"ref259","doi-asserted-by":"publisher","unstructured":"Sato S, Gillette M, de Santiago PR, Kuhn E, Burgess M, Doucette K, et al. LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma. Scientific Reports. 2023; 13: 1537.","DOI":"10.1038\/s41598-023-28840-5"},{"key":"ref260","doi-asserted-by":"publisher","unstructured":"Mombach DM, Mercuri RLV, da Fontoura Gomes TMF, Galante PAF, Loreto ELS. Transposable elements alter gene expression and may impact response to cisplatin therapy in ovarian cancer. Carcinogenesis. 2024; 45: 685\u2013695.","DOI":"10.1093\/carcin\/bgae029"},{"key":"ref261","doi-asserted-by":"publisher","unstructured":"Zhang B, Xing X, Li J, Lowdon RF, Zhou Y, Lin N, et al. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. BMC Genomics. 2014; 15: 868.","DOI":"10.1186\/1471-2164-15-868"},{"key":"ref262","doi-asserted-by":"publisher","unstructured":"Piergentili R, Marinelli E, De Paola L, Cucinella G, Billone V, Zaami S, et al. Epigenetics of Endometrial Cancer: The Role of Chromatin Modifications and Medicolegal Implications. International Journal of Molecular Sciences. 2025; 26: 7306.","DOI":"10.3390\/ijms26157306"},{"key":"ref263","doi-asserted-by":"publisher","unstructured":"Alldredge J, Kumar V, Nguyen J, Sanders BE, Gomez K, Jayachandran K, et al. Endogenous Retrovirus RNA Expression Differences between Race, Stage and HPV Status Offer Improved Prognostication among Women with Cervical Cancer. International Journal of Molecular Sciences. 2023; 24: 1492.","DOI":"10.3390\/ijms24021492"},{"key":"ref264","doi-asserted-by":"publisher","unstructured":"Rezaei SD, Hayward JA, Norden S, Pedersen J, Mills J, Hearps AC, et al. HERV-K Gag RNA and Protein Levels Are Elevated in Malignant Regions of the Prostate in Males with Prostate Cancer. Viruses. 2021; 13: 449.","DOI":"10.3390\/v13030449"},{"key":"ref265","doi-asserted-by":"publisher","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nature Reviews. Cancer. 2017; 17: 223\u2013238.","DOI":"10.1038\/nrc.2017.7"},{"key":"ref266","doi-asserted-by":"publisher","unstructured":"Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2006; 24: 4270\u20134276.","DOI":"10.1200\/JCO.2006.05.9493"},{"key":"ref267","doi-asserted-by":"publisher","unstructured":"Devonshire AS, Whale AS, Gutteridge A, Jones G, Cowen S, Foy CA, et al. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification. Analytical and Bioanalytical Chemistry. 2014; 406: 6499\u20136512.","DOI":"10.1007\/s00216-014-7835-3"},{"key":"ref268","doi-asserted-by":"publisher","unstructured":"Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nature Reviews. Cancer. 2011; 11: 426\u2013437.","DOI":"10.1038\/nrc3066"},{"key":"ref269","doi-asserted-by":"publisher","unstructured":"Barchitta M, Quattrocchi A, Maugeri A, Vinciguerra M, Agodi A. LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis. PloS One. 2014; 9: e109478.","DOI":"10.1371\/journal.pone.0109478"},{"key":"ref270","doi-asserted-by":"publisher","unstructured":"Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, et al. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell. 2015; 162: 974\u2013986.","DOI":"10.1016\/j.cell.2015.07.011"},{"key":"ref271","doi-asserted-by":"publisher","unstructured":"Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell. 2016; 164: 57\u201368.","DOI":"10.1016\/j.cell.2015.11.050"},{"key":"ref272","doi-asserted-by":"publisher","unstructured":"Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019; 570: 385\u2013389.","DOI":"10.1038\/s41586-019-1272-6"},{"key":"ref273","doi-asserted-by":"publisher","unstructured":"De Cecco M, Criscione SW, Peckham EJ, Hillenmeyer S, Hamm EA, Manivannan J, et al. Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell. 2013; 12: 247\u2013256.","DOI":"10.1111\/acel.12047"},{"key":"ref274","doi-asserted-by":"publisher","unstructured":"Ndhlovu LC, Bendall ML, Dwaraka V, Pang AP, Dopkins N, Carreras N, et al. Retroelement-Age Clocks: Epigenetic Age Captured by Human Endogenous Retrovirus and LINE-1 DNA methylation states. bioRxiv. 2023.  (preprint)","DOI":"10.1101\/2023.12.06.570422"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL50970","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:36:21Z","timestamp":1788438981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/8\/10.31083\/FBL50970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":274,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02160-X"],"URL":"https:\/\/doi.org\/10.31083\/fbl50970","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"article-number":"50970"}}